Anthony Petrone Stock Analyst Profile - Mizuho Research Coverage - Stocknear

Anthony Petrone

Stock Analyst at Mizuho

(4.2)
# 1823
Out of 5,493 analysts
198
Total ratings
Success rate
Average return

37 Stocks

Name Action PT Current % Upside Ratings Updated
GH Guardant Health
Maintains: Outperform
65 70
60.03 16.61% 3 Sep 25, 2025
ALC Alcon
Maintains: Outperform
120 110
73.93 48.79% 10 Aug 21, 2025
HAE Haemonetics
Maintains: Outperform
90 70
48.17 45.32% 12 Aug 8, 2025
LNTH Lantheus Holdings
Maintains: Outperform
120 70
50.61 38.31% 6 Aug 7, 2025
RMD ResMed
Maintains: Outperform
270 290
270.31 7.28% 13 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
130 135
120.02 12.48% 9 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
87 95
76.27 24.56% 9 Jul 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
140 135
133.57 1.07% 6 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
105 90
67.55 33.23% 11 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 18
26.8 -32.84% 8 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
98 100
94.22 6.13% 7 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 70
67.21 4.15% 9 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
58 70
39.11 78.98% 7 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
13 12
13.9 -13.67% 3 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
95 100
67.1 49.03% 2 Jul 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 175
80.02 118.7% 10 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
2
n/a n/a 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
20
12 66.67% 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
60
53.57 12% 1 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
54 58
56.29 3.04% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
70 60
53.44 12.28% 8 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 110
98.17 12.05% 8 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 14
15.61 -10.31% 6 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
110 105
72.46 44.91% 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
20 16
n/a n/a 3 Apr 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
250 250
77.23 223.71% 6 Mar 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
6.94 101.73% 4 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
350 390
441.12 -11.59% 6 Jan 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
63 67
84.19 -20.42% 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
75
n/a n/a 2 Jul 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
300
n/a n/a 1 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
200 175
98.24 78.14% 3 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
178
n/a n/a 5 Dec 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 25
12.06 107.3% 3 May 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25 15
n/a n/a 3 May 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
75
n/a n/a 1 Aug 9, 2017